Adjuvant therapy for breast cancer: We are solving the puzzle, but pieces are still missing

Journal of the National Cancer Institute

Volumn 99, Issue 7, 2007, Pages 494-495

  Pritchard, Kathleen I ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTRADIOL; ESTROGEN RECEPTOR; EXEMESTANE; FLUOROURACIL; GONADORELIN AGONIST; GOSERELIN; METHOTREXATE; PROGESTERONE RECEPTOR; TAMOXIFEN; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; EDITORIAL; HORMONE DETERMINATION; HUMAN; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; OVARIECTOMY; OVARY FUNCTION; OVERALL SURVIVAL; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT DURATION; TREATMENT RESPONSE; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; DISEASE FREE SURVIVAL; FEMALE; MORTALITY; MULTIMODALITY CANCER THERAPY; NOTE; PATHOLOGY; SURVIVAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; OVARIECTOMY; RECEPTORS, ESTROGEN; SURVIVAL ANALYSIS;

EID: 34247591403     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djk128     Document Type: Editorial

References (8)

1. The Adjuvant Breast Cancer Trials Collaborative Group. Polychemotherapy for early breast cancer: Results from the International Adjuvant Breast Cancer Chemotherapy Randomized Trial. J Natl Cancer Inst 2007;19:506-15.
2. The Adjuvant Breast Cancer Trials Collaborative Group. Ovarian ablation or suppression in premenopausal early breast cancer: Results from the International Adjuvant Breast Cancer Ovarian Ablation or Suppression Randomized Trial. J Natl Cancer Inst 2007;99:516-25.
3. Davidson NE, O'Neil A, Vukov A, Osborne C, Martino S, White D. Chemohormonal therapy in premenopausal node-positive, receptor-positive breast cancer: An Eastern Cooperative Oncology Group phase III intergroup trial (E5188, INT-0101). Proc Am Soc Clin Oncol 2003;22:5.
4. Arriagada R, Le M, Spielmann M, Mauriac L, Bonneterre J, Namer M. Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy. Proc Am Soc Clin Oncol 2003;22:4.
5. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet 1992;339:1-15;71-85.
6. International Breast Cancer Study Group. SOFT Trial. Available at: http://www.ibcsg.org/public/general_pages/trials/open/ trial_24-02.shtml. [Last accessed: March 7, 2007.]
7. Berry D, Cirrincione C, Henderson IC, Citron M, Budman DR, Goldstein L, et al. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA 2006; 295:1658-67.
8. Albain K, Green SJ, Ravdin PM, Cobau C, Levine E, Ingle J, et al. Adjuvant chemohormonal therapy for primary breast cancer should be sequential instead of concurrent: Initial results from intergroup trial 0100 (SWOG-8814). Proc Am Soc Chn Oncol 2002;21:37a.